BridgeBio Pharma Inc. (BBIO) Said To Attract Interest From Pharma Companies - Bloomberg

(Updated - March 24, 2023 3:58 PM EDT)

BridgeBio Pharma Inc. (NASDAQ: BBIO) is attracting takeover interest from bigger drug companies, according to a report from Bloomberg, citing people familiar with the matter.

Some large pharma companies are studying a potential acquisition of the firm.

Deliberations are ongoing.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Progress Software Corporation (PRGS) Issues Statement on a Possible Offer for MariaDB
• Main Street Capital (MAIN) Announces Follow-On Investments
• Nordstrom (JWN) CEO Erik Nordstrom Reports 7.45% Stake, Seeks to Finance Potential Deal with Debt/Equity